Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis [Phase 3]
This update reports that a Phase 3 randomized trial evaluating Interferon beta for intermediate uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients [Phase 2]
Phase 2 trial evaluating interferon-alpha in multiple sclerosis patients with neutralizing antibodies to interferon-beta; the study status i…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
This update reports 16-year long-term follow-up data for Betaseron in patients with relapsing-remitting multiple sclerosis, highlighting lon…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers [Phase 1]
This Phase 1 trial in healthy volunteers evaluated the bioequivalence of interferon beta-1a produced by two different manufacturing processe…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Combination Therapy Using Cellcept and Rebif in RRMS [EARLY_Phase 1]
The document reports an early-phase 1 clinical trial examining the combination of Cellcept (mycophenolate mofetil) and Rebif (interferon bet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri [Phase 4]
Phase 4 clinical trial update on MRI follow-up of macrophagic infiltration in multiple sclerosis patients treated with natalizumab (Tysabri)…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis [Phase 3]
Phase 3 clinical trial results for teriflunomide in relapsing forms of multiple sclerosis, reporting relapse reduction and disability outcom…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial update comparing the effectiveness and safety of teriflunomide versus interferon beta-1a in relapsing multiple scle…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis [Phase 1]
This Phase 1 study completed evaluating the pharmacokinetics and immunologic effects of alpha-lipoic acid in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis [Phase 2]
Phase II trial evaluating teriflunomide as adjunct to interferon-beta in multiple sclerosis completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis [Phase 2]
Phase II study evaluating teriflunomide as adjunctive therapy to glatiramer acetate in multiple sclerosis; results completed with data poste…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Effect of Melatonin on Multiple Sclerosis Related Fatigue [Phase 2]
A Phase 2 trial evaluated melatonin for multiple sclerosis-related fatigue and has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis [Phase 2]
Phase 2 trial update on efficacy and safety of FTY720 (fingolimod) in relapsing multiple sclerosis completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia [Phase 2]
Phase 2 trial comparing an implanted neuroprosthesis with sensory training to improve airway protection in chronic dysphagia; results were p…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Ginseng in Treatment of Fatigue in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating ginseng for fatigue in people with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses [Phase 2]
A Phase 2 trial assessing teriflunomide for relapsing multiple sclerosis has completed, with reported safety and efficacy outcomes.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: REbif FLEXible Dosing in Early Multiple Sclerosis (MS) [Phase 3]
Phase 3 clinical trial update evaluating flexible dosing of REBIF (interferon beta-1a) in early multiple sclerosis. Results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis [Phase 3]
A Phase 3 parallel-group study compared Sativex with placebo for detrusor overactivity in patients with multiple sclerosis; the trial is com…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients [Phase 3]
Phase 3 clinical trial investigating THC and CBD in multiple sclerosis has completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis [Phase 3]
Phase 3 clinical trial investigating Sativex for central neuropathic pain in multiple sclerosis has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating THC and CBD in multiple sclerosis completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. [Phase 3]
Phase 3 clinical trial update for Sativex® in relief of spasticity in multiple sclerosis; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Motor Training and White Matter in Multiple Sclerosis (MS) [NA]
A clinical trial investigating motor training and white matter in multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
Long-term study update of fingolimod in multiple sclerosis from the FTY clinical program; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients [Phase 4]
This Phase 4 trial evaluating the combination of interferon beta and vitamin D in relapsing-remitting multiple sclerosis was terminated.